Susquehanna Fundamental Investments, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Susquehanna Fundamental Investments, LLC
- $4.33 Trillion
- Q2 2024
Shares
3 transactions
Others Institutions Holding AMPH
# of Institutions
282Shares Held
35.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$317 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$143 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$114 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$104 Million0.19% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$86.6 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.62B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...